Recent News

Quanterix Named Final Winner of NFL and GE Head Health Challenge I

July 23, 2015
Not Flagship

Joule Appoints Peter Matrai CFO, Biofuels industry veteran brings expertise in commercialization of new technologies

July 22, 2015
Not Flagship

Denali Therapeutics Appoints Carole Ho, M.D., as Chief Medical Officer and Head of Development

July 22, 2015
Not Flagship

Red Rock Reaches Agreement with FedEx Express to Provide Biofuels for Renewable, Low-Carbon Jet Fuel

July 21, 2015
Not Flagship

Editas Medicine Appoints Andrew Hack, M.D., Ph.D., as Chief Financial Officer

July 1, 2015
Not Flagship

Seres Therapeutics, Inc. Announces Pricing of Initial Public Offering

June 25, 2015
Not Flagship

Agios Announces First Patient Dosed with AG-881 in Phase 1 Study in Patients with Advanced Solid Tumors with an IDH Mutation

June 24, 2015
Not Flagship

T2 Biosystems Presents Data From Two Studies Evaluating T2MR in Hemostasis at the International Society on Thrombosis and Haemostasis Annual Congress

June 23, 2015
Not Flagship

BIND Therapeutics Announces FDA Authorization of First-in-Human Clinical Trial with AstraZeneca's Aurora B Kinase Inhibitor Accurin AZD2811

June 23, 2015
Not Flagship

Joule Expands Intellectual Property on Direct Conversion of CO2 to Hydrocarbons

June 16, 2015
Not Flagship

Acceleron Announces Publication in Cancer Research Demonstrating Dalantercept Prevents Metastases in Preclinical Studies of Breast Cancer

June 15, 2015
Not Flagship

Agios Reports New, Final Data from Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers for AG-348, an Investigational Medicine for Pyruvate Kinase (PK) Deficiency

June 12, 2015
Not Flagship

Agios Announces New Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies

June 12, 2015
Not Flagship

Agios Announces New Data from Ongoing Phase 1 Dose Escalation and Expansion Trial of AG-221 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies

June 12, 2015
Not Flagship

BIND Therapeutics and Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin™ Nanoparticle Using Manocept™ Macrophage Targeting Platform

June 12, 2015
Not Flagship

Acceleron Announces New Luspatercept Phase 2 Clinical Results at the 20th Congress of the European Hematology Association

June 12, 2015
Not Flagship

Seres Therapeutics Receives FDA Breakthrough Therapy Designation for Its Lead Product Candidate, SER-109

June 12, 2015
Not Flagship

Seres Therapeutics, Inc. Elects Dennis Ausiello, M.D., to Board of Directors

June 11, 2015
Not Flagship

Selecta Biosciences Initiates Phase 1 Clinical Program of SEL-212, Designed As the First Non-Immunogenic Biologic Treatment for Gout

June 10, 2015
Not Flagship

Flagship Ventures Welcomes 16 VentureLabs® Fellows Commencing Its Seventh Annual Fellowship Program

June 10, 2015
Is Flagship Story

Agios Pharmaceuticals Announces FDA Orphan Drug Designation Granted to AG-120 for Treatment of IDH1-Mutant Positive Acute Myelogenous Leukemia

June 10, 2015
Not Flagship

Pronutria Biosciences Announces Key Additions to Executive Team

June 2, 2015
Not Flagship

Pronutria Biosciences Raises $39 Million in Series C Financing

May 28, 2015
Not Flagship

Seres Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of SER-109 for the Prevention of Recurrent Clostridium difficile Infection in Adults

May 28, 2015
Not Flagship

Juno Therapeutics and Editas Medicine Announce Exclusive Collaboration to Create Next-Generation CAR T and TCR Cell Therapies

May 27, 2015
Not Flagship

Visterra Partners with A*STAR to Develop VIS513, a Monoclonal Antibody for Dengue

May 21, 2015
Not Flagship

Agios Announces FDA Fast Track Designation Granted to AG-120 for Treatment of Patients with Acute Myelogenous Leukemia with an IDH1 Mutation

May 18, 2015
Not Flagship

FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Beta-Thalassemia

May 18, 2015
Not Flagship

Editas Medicine Presents Data from Multiple Therapeutic Discovery Programs Emerging from its Genome Editing Platform at the ASGCT Annual Conference

May 18, 2015
Not Flagship

Denali Therapeutics Launches with Initial Investment to Discover and Develop Treatments for Neurodegenerative Diseases

May 14, 2015
Not Flagship

Sanofi Exercises Option on Second Therapeutic Program with Selecta Biosciences to Develop an Antigen-Specific Immunotherapy Based on Synthetic Vaccine Particle Technology

May 13, 2015
Not Flagship

Selecta and Genethon Collaborate to Create Next Generation Gene Therapies Using Selecta’s Synthetic Vaccine Particle Platform

May 13, 2015
Not Flagship

Moderna Launches Third Venture Company Elpidera for Rare Diseases

May 12, 2015
Not Flagship

Moderna #1 on CNBC Disruptor 50 List

May 12, 2015
Not Flagship

Joule’s CO2-Recycled Ethanol Meets U.S. and European Specifications

May 11, 2015
Not Flagship

Joule Secures $40 Million for Continued Growth

May 11, 2015
Not Flagship

Concert Pharmaceuticals Reports First Quarter 2015 Financial Results

May 8, 2015
Not Flagship

Acceleron Pharma Reports First Quarter 2015 Financial and Operational Results

May 7, 2015
Not Flagship

Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120

May 7, 2015
Not Flagship

BIND Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update

May 7, 2015
Not Flagship

Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis at ARVO 2015 Annual Meeting

May 7, 2015
Not Flagship

Editas Medicine Announces Six Scientific Presentations at the American Society of Gene And Cell Therapy 18th Annual Meeting

May 6, 2015
Not Flagship

Flagship Ventures Forms Strategic Innovation Partnerships with AstraZeneca, Nestlé Health Science and Bayer CropScience

May 5, 2015
Is Flagship Story

Eleven Biotherapeutics Presents Data on EBI-031 for the Treatment of Diabetic Macular Edema at ARVO 2015 Annual Meeting

May 5, 2015
Not Flagship

T2 Biosystems Reports 2015 First Quarter Results

May 5, 2015
Not Flagship

Celgene and Acceleron Select Luspatercept to Advance to Phase 3 in Myelodysplastic Syndromes

April 30, 2015
Not Flagship

Eleven Biotherapeutics Reports First Quarter 2015 Financial Results

April 30, 2015
Not Flagship

Syros Pharmaceuticals Augments Senior Leadership Team

April 30, 2015
Not Flagship

Agios Pharmaceuticals Selects Third Novel IDH Mutant Inhibitor, AG-881, for Clinical Development

April 29, 2015
Not Flagship

Eleven Biotherapeutics Publishes Clinical Data on EBI-005 for the Treatment of Allergic Conjunctivitis

April 29, 2015
Not Flagship

Vic Myer, Ph.D. Joins Editas Medicine as Chief Technology Officer

April 27, 2015
Not Flagship

BIND Therapeutics Presents Data Highlighting Ability of Accurins to Control Biodistribution and Accumulate in Target Tissue at AACR Annual Meeting 2015

April 22, 2015
Not Flagship

Blend Therapeutics Presents Preclinical Data for Lead Candidate BTP-114 that Demonstrated Superiority to Cisplatin in Tumor Growth Inhibition

April 21, 2015
Not Flagship

Blend Therapeutics Presents Preclinical Data for Lead Pentarin™ Program, BTP-277, Demonstrating Specific and Potent Tumor Cell Targeting for Small-Cell Lung Cancer

April 21, 2015
Not Flagship

Eleven Biotherapeutics Presents Phase 2 Clinical Data on EBI-005 for the Treatment of Allergic Conjunctivitis at ASCRS 2015 Annual Meeting

April 16, 2015
Not Flagship

Avedro Expands Patent Portfolio with Licenses from Caltech and IROC Innocross

April 14, 2015
Not Flagship

Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer

April 13, 2015
Not Flagship

Agenus Acquires Celexion Assets and Expands Its Antibody Discovery Platform

April 8, 2015
Not Flagship

Study Published in Future Microbiology Demonstrates Significant Cost and Survival Benefits for T2 Biosystems' T2Candida Panel for Sepsis

April 8, 2015
Not Flagship

Acceleron Pharma Appoints Dr. Francois Nader as Chairman of its Board of Directors

April 6, 2015
Not Flagship

BIND Therapeutics Announces Extension of Global Collaboration with Pfizer Inc. to Develop and Commercialize Multiple Accurins

April 2, 2015
Not Flagship

Flagship Ventures Closes $537 million for its Fifth Fund

March 26, 2015
Is Flagship Story

Pronutria Biosciences™ Appoints Dr. Christopher Wright as Senior Vice President and Chief Medical Officer

March 24, 2015
Not Flagship

Agios Pharmaceuticals Announces Orphan Drug Designation of AG-348 for Treatment of Pyruvate Kinase Deficiency

March 24, 2015
Not Flagship

Syros Pharmaceuticals Announces New Research Published on Role of Cell Signaling Pathways in Gene Control

March 20, 2015
Not Flagship

Investment from Flagship Ventures Brings Red Rock Biofuels Closer to Construction of its First Commercial Biofuel Refinery

March 17, 2015
Not Flagship

Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer

March 16, 2015
Not Flagship

Concert Pharmaceuticals Initiates Phase 1 Trial Evaluating Deuterated Ivacaftor for Cystic Fibrosis

March 12, 2015
Not Flagship

BIND Therapeutics Appoints Andrew Hirsch as Acting President and Chief Executive Officer

March 10, 2015
Not Flagship

Acceleron Pharma Announces Executive Appointments and Promotions

March 6, 2015
Not Flagship

Quanterix Expands Kevin Hrusovsky’s Role to CEO

March 4, 2015
Not Flagship

Eleven Biotherapeutics Reports Fourth Quarter and Year-End 2014 Financial Results

March 4, 2015
Not Flagship

Joule Receives Prestigious Frost & Sullivan Technology Innovation Award

March 2, 2015
Not Flagship

Editas Medicine Reports New Data Demonstrating Potential of CRISPR/Cas9 Construct as Novel Gene Repair Mechanism

March 2, 2015
Not Flagship

Acceleron Pharma Reports Fourth Quarter and Year Ended 2014 Financial and Operational Results

March 2, 2015
Not Flagship

Acceleron Presents Encouraging Response Rates and Progression-Free Survival Data in Patients with Advanced Renal Cell Carcinoma at the American Society of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium

February 28, 2015
Not Flagship

Concert Pharmaceuticals Reports Year End 2014 Financial Results

February 27, 2015
Not Flagship

FDA Advisory Committee Recommends Approval for Avedro’s Riboflavin Ophthalmic Solutions with UVA Irradiation for Corneal Collagen Cross-Linking to Treat Progressive Keratoconus and Corneal Ectasia

February 27, 2015
Not Flagship

Joule Is Poised For Significant Progress in 2015

February 23, 2015
Not Flagship

Avedro Announces Date for FDA Advisory Committee Meeting

February 17, 2015
Not Flagship

Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results

February 17, 2015
Not Flagship

Syros Pharmaceuticals Presents New Data on Use of its Gene Control Platform for Predicting Drug Response

February 10, 2015
Not Flagship

Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer

February 4, 2015
Not Flagship

Moderna and Institut Pasteur Sign Strategic Research Collaboration

February 3, 2015
Not Flagship

Symbiota Names Global Crop Protection Expert Peter Innes, Ph.D. to Board of Directors

February 3, 2015
Not Flagship

T2 Biosystems and Canon U.S. Life Sciences Announce Joint Collaboration to Develop Novel Test Panel to Rapidly Detect Lyme Disease

February 3, 2015
Not Flagship

Acceleron Pharma to Present at Upcoming Investor Conferences in February

January 28, 2015
Not Flagship

Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors

January 22, 2015
Not Flagship

BIND Therapeutics Co-Founder Publishes Nanotechnology Article in the Journal of the American Medical Association

January 22, 2015
Not Flagship

Seres Health Announces Addition of Mark Wilcox, M.D. to Scientific Advisory Board

January 21, 2015
Not Flagship

Avedro Appoints Brian Roberts as Chief Financial Officer

January 20, 2015
Not Flagship

Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer

January 15, 2015
Not Flagship

Pivotal Data for T2Candida and T2Dx Published in Clinical Infectious Diseases

January 13, 2015
Not Flagship

Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies

January 13, 2015
Not Flagship

Oasys Water’s Global Momentum Continues with Asia-Pacific Expansion and Deployment of its Forward Osmosis Systems

January 13, 2015
Not Flagship

Report Published in The Journal of the American Medical Association Highlights Impact of T2 Biosystems' T2MR Technology in Diagnosing Infections

January 13, 2015
Not Flagship

Acceleron Pharma Outlines Corporate Objectives for 2015

January 12, 2015
Not Flagship

Editas Medicine Reports New Data Characterizing Novel Properties of Staphylococcus aureus Cas9 as a Tool for CRISPR-Based Genome Engineering

January 12, 2015
Not Flagship

Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration

January 12, 2015
Not Flagship

Moderna Launches New Venture Valera LLC for Infectious Diseases

January 8, 2015
Not Flagship

T2 Biosystems to Present at the 33rd Annual J.P. Morgan Healthcare Conference

January 8, 2015
Not Flagship

Onkaido Announces Appointment of Michael J. Morin, Ph.D., as Chief Scientific Officer

January 7, 2015
Not Flagship

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics

January 7, 2015
Not Flagship

Symbiota Names Entrepreneurial Leader David P. Perry as President and CEO

January 7, 2015
Not Flagship

Syros Pharmaceuticals to Present at the 33rd Annual J.P. Morgan 2015 Healthcare Conference

January 7, 2015
Not Flagship

Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors

January 7, 2015
Not Flagship

BIND Therapeutics Provides Clinical Update for BIND-014 and 2015 Strategic Overview

January 7, 2015
Not Flagship

Moderna to Present at 33rd Annual J.P. Morgan Healthcare Conference

January 6, 2015
Not Flagship

Seres Health Announces $65 Million Investment from Nestlé Health Science

January 6, 2015
Not Flagship

Moderna Closes $450 Million Financing to Support Growth of Messenger RNA Therapeutics™ Platform across Diverse Therapeutic Areas

January 5, 2015
Not Flagship

Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12

January 5, 2015
Not Flagship

Selecta and Skolkovo Foundation Collaboration to Develop a Synthetic Vaccine Particle in the field of Immuno-oncology

December 23, 2014
Not Flagship

Pronutria Biosciences Announces Issuance of Key Patents from USPTO on Compositions and Methods Relating to Oral Biologics

December 18, 2014
Not Flagship

Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option

December 16, 2014
Not Flagship

Quanterix Announces the Simoa Accelerator, an Innovation Center for Biomarker Research and Custom Assay Development

December 16, 2014
Not Flagship

Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors

December 12, 2014
Not Flagship

Syros Pharmaceuticals Presents New Data from Its Gene Control Platform at Oncology Conferences

December 11, 2014
Not Flagship

Syros Pharmaceuticals Announces New Research Published on CDK7 in Lung and Pediatric Cancers

December 11, 2014
Not Flagship

Symbiota Appoints International Plant Sciences Leader Dr. Roger Beachy to its Board of Directors

December 10, 2014
Not Flagship

Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors

December 10, 2014
Not Flagship

Concert Pharmaceuticals Names Thomas Auchincloss to Board of Directors and Chair of the Audit Committee

December 10, 2014
Not Flagship

Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update

December 9, 2014
Not Flagship

Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016

December 8, 2014
Not Flagship

Pronutria Adds Industry Leaders to its Board of Directors

December 8, 2014
Not Flagship

Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency

December 8, 2014
Not Flagship

New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition

December 8, 2014
Not Flagship

Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies

December 7, 2014
Not Flagship

New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition

December 7, 2014
Not Flagship

Pronutria Appoints Dr. Peter Mueller as President of R&D and Chief Scientific Officer

December 4, 2014
Not Flagship

Seres Health Closes $48 Million Series C Financing

December 2, 2014
Not Flagship

Broad Institute, Harvard, And MIT License CRISPR-Cas9 Technology To Editas Medicine For Therapeutic Applications

December 1, 2014
Not Flagship

Editas Medicine Licenses Genome Editing Technology from Duke University

December 1, 2014
Not Flagship

Editas Medicine Licenses Genome Editing Technology from Massachusetts General Hospital

December 1, 2014
Not Flagship

Eleven Biotherapeutics Announces Additional Financing of $20 Million

November 25, 2014
Not Flagship

TIME's Best Inventions List Also Includes an Edible Invention from Cambridge

November 24, 2014
Not Flagship

BIND Therapeutics Presents Positive Phase 2 Results Highlighting Potential of BIND-014 as Novel Anti-Cancer Treatment at Q3W Dosing Schedule for Patients with Non-small Cell Lung Cancer at 26th EORTC-NCI-AACR Annual Symposium

November 19, 2014
Not Flagship

Black Duck Software Appoints Global Sales Veteran Adam Clay as Vice President of Worldwide Sales

November 18, 2014
Not Flagship

Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)

November 18, 2014
Not Flagship

Seres Health Appoints Biotechnology Finance Leader Eric Shaff as Chief Financial Officer

November 17, 2014
Not Flagship

Eleven Biotherapeutics Reports Third Quarter 2014 Financial Results

November 13, 2014
Not Flagship

Flagship VentureLabs™ Introduces Symbiota, Pioneer of Agricultural Innovation Through the Plant Microbiome

November 13, 2014
Not Flagship

Joule Names Industry Veteran Serge Tchuruk as President and CEO

November 13, 2014
Not Flagship

Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program

November 12, 2014
Not Flagship

Avedro Granted Korean Approval for its KXL® Cross-Linking System for Lasik Xtra®

November 7, 2014
Not Flagship

Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results

November 7, 2014
Not Flagship

Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results

November 7, 2014
Not Flagship

BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology

November 6, 2014
Not Flagship

BIND Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update

November 6, 2014
Not Flagship

Syros Pharmaceuticals’ Scientists Publish New Method to Detect Epigenomic Changes Following Drug Treatment

November 6, 2014
Not Flagship

BIND Therapeutics Appoints Hagop Youssoufian, M.Sc., M.D. as Chief Medical Officer

November 4, 2014
Not Flagship

Mascoma Completes the Sale of its Yeast Business to Lallemand Inc.

November 4, 2014
Not Flagship

T2 Biosystems Reports 2014 Third Quarter Highlights and Financial Results

November 4, 2014
Not Flagship

Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of EBI-005 in Patients with Dry Eye Disease

November 3, 2014
Not Flagship

Visterra Announces Additions to its Management Team and Board of Directors

October 31, 2014
Not Flagship

Nielsen Acquires Affinnova

October 30, 2014
Not Flagship

Syros Pharmaceuticals Closes $53 Million Series B Financing

October 27, 2014
Not Flagship

Novomer Announces First Commercial Adoption of Converge® Polyols for Polyurethane Adhesives

October 27, 2014
Not Flagship

The TransMedics® Organ Care System (OCS™) Heart Technology Was Used to Perform The World’s First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincent’s Hospital in Sydney, Australia

October 24, 2014
Not Flagship

Eleven Biotherapeutics Appoints Wendy L. Dixon, PhD to Board of Directors

October 23, 2014
Not Flagship

Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation

October 21, 2014
Not Flagship

Moderna to Collaborate with Karolinska Institutet and Karolinska University Hospital on Discovery of New Messenger RNA Therapeutics™

October 16, 2014
Not Flagship

Selecta, JDRF and Sanofi Extend Collaboration to Develop a Synthetic Vaccine Particle Immunotherapy for Type 1 Diabetes

October 15, 2014
Not Flagship

Selecta Announces More than $20 Million in Equity Funding

October 15, 2014
Not Flagship

Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221

October 15, 2014
Not Flagship

Syros Pharmaceuticals’ Scientific Founders Publish New Research on Gene Control Mechanisms

October 14, 2014
Not Flagship

Acceleron Initiates Phase 1 Clinical Trial with Innovative Muscle Drug ACE-083

October 14, 2014
Not Flagship

Concert Pharmaceuticals Presents Positive Data from Multiple Dose Phase 1 Clinical Trial of CTP-354, Lead Candidate for the Treatment of Spasticity

October 13, 2014
Not Flagship

Oasys Water Named to the 2014 Global Cleantech 100

October 7, 2014
Not Flagship

Eleven Biotherapeutics Granted U.S. Composition-of-Matter Patent for EBI-005

October 7, 2014
Not Flagship

Seres Health Appoints Two New Board Members

October 6, 2014
Not Flagship

Eleven Biotherapeutics Announces Top-Line Results from Phase 2 Study of EBI-005 in Patients with Moderate to Severe Allergic Conjunctivitis

October 2, 2014
Not Flagship

Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases

October 2, 2014
Not Flagship

Avedro Announces Resubmission of New Drug Application to FDA for Corneal Cross-Linking

September 30, 2014
Not Flagship

Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014

September 26, 2014
Not Flagship

Syros Pharmaceuticals Presents Research on Gene Control in Acute Myeloid Leukemia at AACR Hematologic Malignancies Meeting

September 23, 2014
Not Flagship

FierceBiotech names Editas Medicine as one of its “Fierce 15” Biotech Companies of 2014

September 22, 2014
Not Flagship

Seres Health Named a "Fierce 15" Biotech Company for 2014

September 22, 2014
Not Flagship

T2 Biosystems Receives FDA Authorization to Market T2Candida and T2Dx for the Detection of Sepsis-Causing Pathogens

September 22, 2014
Not Flagship

Concert Pharmaceuticals Announces Initiation of CTP-730 Phase 1 Clinical Trial Under Celgene Collaboration

September 17, 2014
Not Flagship

Joule to Team with DNV GL for Commercial Validation of Transformative CO2-to-Fuels Production Process

September 17, 2014
Not Flagship

Dr. Mark Roskey Joins Quanterix Leadership Team

September 16, 2014
Not Flagship

Seres Health Presents Final Data for Study of SER-109 in Recurrent Clostridium difficile Infection at ICAAC 2014 Conference

September 8, 2014
Not Flagship

Joule and Scatec Solar ASA to Align for Photovoltaic-Powered Solar Fuel Production

September 5, 2014
Not Flagship

CPI Announces Finalists For 2013 Polyurethane Innovation Award

September 5, 2014
Not Flagship

Avedro Acquires Assets of IROC Innocross AG, Including its UV-X Line of Cross-Linking Devices

September 3, 2014
Not Flagship

BIND Therapeutics Appoints Two New Board Members

September 3, 2014
Not Flagship

Oasys Water Continues Growth and Commercialization Momentum in Global Markets

September 2, 2014
Not Flagship

Seres Health to Present Clinical Findings at ICAAC 2014 Conference

August 28, 2014
Not Flagship

Joule to Host Strategic Seminar on Climate Change in Norway, Featuring Jeffrey Sachs

August 28, 2014
Not Flagship

Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration

August 26, 2014
Not Flagship

Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner

August 25, 2014
Is Flagship Story

Joule Achieves Industry First With A 100% Increase In Photosynthetic Efficiency

August 15, 2014
Not Flagship

Eleven Biotherapeutics Reports Second Quarter 2014 Financial Results

August 13, 2014
Not Flagship

Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation

August 13, 2014
Not Flagship

Seventh Sense Biosystems Closes $16 Million Series B Financing

August 13, 2014
Not Flagship

Allergan Acquires LiRIS® Program from TARIS Biomedical®

August 13, 2014
Not Flagship

Acceleron Pharma Reports Second Quarter 2014 Financial Results

August 12, 2014
Not Flagship

Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update

August 12, 2014
Not Flagship

Joule to Present Transformative Climate Change Solution at Arendal Week

August 12, 2014
Not Flagship

T2 Biosystems Announces Pricing of Initial Public Offering

August 7, 2014
Not Flagship

Is this the next big leap for organ transplants?

August 7, 2014
Not Flagship

BIND Therapeutics Reports Second Quarter 2014 Financial Results

August 7, 2014
Not Flagship